Factors influencing prognosis after dose-intensive therapy for recurrent or refractory Hodgkin's disease. Results of sequential trials: a case for treating patients with resistant disease

MeSH terms

• Adolescent
• Adult
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bone Marrow Transplantation
• Carboplatin / administration & dosage
• Carmustine / administration & dosage
• Clinical Trials as Topic
• Cohort Studies
• Combined Modality Therapy
• Cyclophosphamide / administration & dosage
• Cytarabine / administration & dosage
• Drug Resistance
• Etoposide / administration & dosage
• Female
• Hodgkin Disease / drug therapy*
• Hodgkin Disease / mortality
• Hodgkin Disease / pathology
• Hodgkin Disease / therapy
• Humans
• Male
• Middle Aged
• Mitoxantrone / administration & dosage
• Prognosis
• Recurrence
• Survival Rate
• Thiotepa / administration & dosage
• Treatment Outcome
• Vinblastine / administration & dosage